PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Surgery
October 16, 2019 07:00 ET
|
PolyPid, Ltd.
D-PLEX100 Administration into the Surgical Site Led to Statistically Significant Reduction in Infections Compared to Standard of Care Alone Company Intends to Hold End of Phase 2 Meeting with FDA and...